Hydralazine Hydrochloride NDC 67877-292

NDC codes

FDA NDC Directory

Product NDC (as listed)67877-292Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67877-0292Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
67877-292-01	67877029201	100 TABLET in 1 BOTTLE (67877-292-01)Marketed from May 24, 2010
67877-292-05	67877029205	500 TABLET in 1 BOTTLE (67877-292-05)Marketed from May 24, 2010
67877-292-10	67877029210	1000 TABLET in 1 BOTTLE (67877-292-10)Marketed from May 24, 2010

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Hydralazine Hydrochloride
Generic name (nonproprietary): hydralazine hydrochloride
Active ingredients: Hydralazine hydrochloride — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Ascend Laboratories, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 200737
Marketing start: May 24, 2010
Listing expires: Dec 31, 2026
Other FDA classes: Arteriolar Vasodilation (Physiologic effect)
Identifiers: Product ID 67877-292_26a904df-7070-489e-b0e0-67167a817944SPL ID 26a904df-7070-489e-b0e0-67167a817944SPL set ID e7bfec3d-5222-4a26-8f99-6c2a28e14aa6RxCUI 905199, 905222, 905225, 905395UNII FD171B778YUPC 0367877293011
Pharmacologic class: Arteriolar Vasodilator

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N467877029201 followed by a unit qualifier and the quantity

Package 67877-0292-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 28, 2017.

Indications (excerpt from the label)

INDICATIONS & USAGE Essential hypertension, alone or as an adjunct.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 200737

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 200737
Product	Strength	Form · route	Labeler	Product NDC
Hydralazine Hydrochloride	Hydralazine hydrochloride 10 mg/1	TabletOral	Ascend Laboratories, LLC	67877-293
Hydralazine Hydrochloride	Hydralazine hydrochloride 100 mg/1	TabletOral	Ascend Laboratories, LLC	67877-290
Hydralazine Hydrochloride	Hydralazine hydrochloride 50 mg/1	TabletOral	Ascend Laboratories, LLC	67877-291